Literature DB >> 15345218

Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.

Lisheng Wang1, Li Li, Farbod Shojaei, Krysta Levac, Chantal Cerdan, Pablo Menendez, Tanya Martin, Anne Rouleau, Mickie Bhatia.   

Abstract

The cellular organization and relationships among precursors that initiate embryonic angiogenesis and hematopoiesis in the human have yet to be characterized. Here, we identify a subpopulation of primitive endothelial-like cells derived from human embryonic stem cells (hESCs) that express PECAM-1, Flk-1, and VE-cadherin, but not CD45 (CD45negPFV cells), and that are uniquely responsible for endothelial and hematopoietic development. Molecular profiling of CD45negPFV cells is consistent with endothelial and hematopoietic competency. Clonal isolation demonstrates that the CD45negPFV population includes bipotent cells with endothelial and hematopoietic capacity. We suggest that human hematopoiesis and endothelial maturation originate exclusively from a subset of embryonic endothelium that possesses hemangioblastic properties and offers a model system to study these lineage relationships in the human.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345218     DOI: 10.1016/j.immuni.2004.06.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  130 in total

Review 1.  Vascular potential of human pluripotent stem cells.

Authors:  Ionela Iacobas; Archana Vats; Karen K Hirschi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

2.  Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

Authors:  Veronica Ramos-Mejia; Gustavo J Melen; Laura Sanchez; Ivan Gutierrez-Aranda; Gertrudis Ligero; Jose L Cortes; Pedro J Real; Clara Bueno; Pablo Menendez
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

Review 3.  Hematopoiesis from pluripotent stem cell lines.

Authors:  Hiroshi Sakamoto; Kiyomi Tsuji-Tamura; Minetaro Ogawa
Journal:  Int J Hematol       Date:  2010-02-20       Impact factor: 2.490

4.  Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation.

Authors:  Ruijun Tian; Shuai Wang; Fred Elisma; Li Li; Hu Zhou; Lisheng Wang; Daniel Figeys
Journal:  Mol Cell Proteomics       Date:  2010-06-08       Impact factor: 5.911

5.  Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells.

Authors:  Li Li; Bill H Wang; Shuai Wang; Lilian Moalim-Nour; Kanishka Mohib; David Lohnes; Lisheng Wang
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

6.  Characterization of human embryonic stem cell-derived hematopoietic progenitor phenotype.

Authors:  Hai-Yang Zhou; Xiao-Yi Yang; Li-Jian Tao; Yue-Tian Chang; Ru-Ping Dai
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-07-10       Impact factor: 2.416

7.  The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells.

Authors:  Emerson E Sharpe; Amylynn A Teleron; Bin Li; James Price; Mark S Sands; Kathy Alford; Pampee P Young
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 8.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 9.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

10.  Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells.

Authors:  Petter S Woll; Julie K Morris; Matt S Painschab; Rebecca K Marcus; Aimee D Kohn; Travis L Biechele; Randall T Moon; Dan S Kaufman
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.